METHOTREXATE REDUCED TNF BIOACTIVITY BY ANTI-INFLIXIMAB ANTIBODY PREVENTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB

被引：0
|
作者：
Denarie, D. [1 ]
Rinaudo, M. [2 ]
Thomas, T. [1 ]
Paul, S. [2 ]
Marotte, H. [1 ]
机构：
[1] Chu St Etienne France, Rheumatol Unit, St Etienne, France
[2] Chu St Etienne France, Immunol & Immunomonitoring Dept, St Etienne, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3296
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0109
引用
收藏
页码：459 / 459
页数：1
相关论文
共 50 条
  • [1] Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
    Denarie, Delphine
    Rinaudo-Gaujous, Melanie
    Thomas, Thierry
    Paul, Stephane
    Marotte, Hubert
    [J]. MEDIATORS OF INFLAMMATION, 2017, 2017
  • [2] The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
    Plasencia-Rodriguez, Chamaida
    Pascual-Salcedo, Dora
    Gema Bonilla, Maria
    Villalba, Alejandro
    Peiteado, Diana
    Nuno, Laura
    Aguado, Pilar
    Jurado, Teresa
    Martin-Mola, Emilio
    Balsa, Alejandro
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1098 - S1098
  • [3] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
  • [4] ESTABLISHING CUT-OFF OF INFLIXIMAB AND ANTI-INFLIXIMAB ANTIBODY LEVELS USING A COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, D.
    De la Torre, I.
    Martinez, L.
    Nieto, J.
    Llinares, F.
    Rosas, J.
    Gonzalez, C.
    Monteagudo, I.
    Lopez-Longo, J.
    Montoro, M.
    Carreno, L.
    Valor, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 237 - 237
  • [5] Anti-infliximab antibodies in RA patients treated with infliximab.
    Wolbink, GJ
    Lems, WF
    Nurmohamed, MT
    Vis, M
    Voskuyl, AE
    Stapel, S
    de Groot, E
    Tak, PP
    Dijkmans, BA
    Aarden, L
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S187 - S187
  • [6] Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
    Svenson, M.
    Geborek, P.
    Saxne, T.
    Bendtzen, K.
    [J]. RHEUMATOLOGY, 2007, 46 (12) : 1828 - 1834
  • [7] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    [J]. JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [8] Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab
    Wiland, P
    Wiela-Hojenska, A
    Glowska, A
    Chlebicki, A
    Hurkacz, M
    Orzechowska-Juzwenko, K
    Szechinski, J
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (04) : 469 - 472
  • [9] Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab
    Wiland, P
    Wiela-Hojenska, A
    Glowska, A
    Chlebicki, A
    Hurkacz, M
    Orzechowska-Juzwenko, K
    Szechinski, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 177 - 177
  • [10] Anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 385 - 386
12345